Sort
78,016 grants matching “breast cancer”
Macrophage phenotype polarization in clinical neoplasia
$550,086Jan Matt Van De Rijn · Stanford University · R01 · FY2021 · CA
Methods for Epidemiology Studies
$550,070Paul Albert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Characterization and modeling of m6A RNA methylation in cancer
$550,031Han Liang · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Testing a narrative intervention to enhance genetic counseling and testing
$550,008Alejandra Hurtado De Mendoza Casaus · Georgetown University · R01 · FY2025 · CA
PS-OC BIORESOURCE CORE FACILITY (PBCF)
$550,000 · N01 · FY2010 · CA
EPIDEMIOLOGY OF MOLECULAR RISK FACTORS FOR BREAST CANCER
$550,000Vanderbilt University · R01 · FY2000 · CA
Texas Center for Minority Health, Education, Research and Outreach
$550,000Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · U54 · FY2022 · MD
Alliance for Clinical Trials in Oncology Operations Center
$550,000Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2016 · CA
CAREER: Super-resolution in coherent anti-Stokes Raman scattering (CARS) microscopy
$550,000Eric O Potma · University Of California-Irvine · · FY2009 · MPS
Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor
$549,997John Andrew Kalapurakal · Northwestern University At Chicago · R01 · FY2020 · CA
Atlanta Regional Community Clinical Oncology Program
$549,987St. Joseph'S Hospital · U10 · FY2005 · CA
Biomarkers for Staging and Treatment Response Monitoring of Bladder Cancer
$549,985Lubomir M Hadjiyski · University Of Michigan At Ann Arbor · U01 · FY2016 · CA
Variability of Cellular Responses to Growth Factors and Drugs During Tumorgenesis
$549,980Gregoire Altan-Bonnet · Sloan-Kettering Inst Can Research · U54 · FY2012 · CA
VANGUARD CENTER FOR WOMEN'S HEALTH INITIATIVE
$549,953Emory University · N01 · FY2000 · WH
Network Analysis for a Data-Driven Approach to Cancer Care
$549,950Jeremy Lyle Warner · Vanderbilt University Medical Center · U01 · FY2019 · CA
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses tohirsutinolides
$549,875James K Turkson · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Modeling the Impact of Targeted Therapy Based on Breast Cancer Subtypes
$549,851Laura J Esserman · University Of California, San Francisco · U01 · FY2015 · CA
Optimized Digital Mammography with an a-Se FP Imager
$549,843University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
An integrated theranostic system for breast cancer
$549,817Elisa E Konofagou · Columbia University Health Sciences · R01 · FY2020 · CA
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab
$549,804Edith A Perez · Mayo Clinic Jacksonville · R01 · FY2012 · CA
Role of O-GlcNAcome on Breast Cancer Initiating Cells
$549,794Mauricio J. Reginato · Drexel University · U01 · FY2023 · CA
Role of O-GlcNAcome on Breast Cancer Initiating Cells
$549,794Mauricio J. Reginato · Drexel University · U01 · FY2022 · CA
Novel, Noninvasive, Rapid Tumor Ablation Technology using Histotripsy
$549,773Zhen Xu · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Imaging and Targeting Metastatic-Prone Breast Cancer
$549,750Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Modeling Response to HER2 target therapies
$549,709Joe W. Gray · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2010 · CA